0.43 | 1.18%
| Price and Volume | |
|---|---|
| Recent Price | 36.93 |
| 52 Week High | 40.51 |
| 52 Week Low | 29.76 |
| Avg. Daily Vol. (Mil) | 1.20 |
| Beta (3 year) | 0.91 |
| Share Related Items | |
| Mkt Cap (Mil) | 2,197.08 |
| Shares Out (Mil) | 59.49 |
| Float (Mil) | 50.69 |
| Dividend Information | |
| Yield % | 1.10 |
| Annual Dividend | 0.40 |
| Payout Ratio | 20.00 |
| Financial Strength | |
| Quick Ratio | 0.90 |
| Current Ratio | 1.00 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.20 |
| Valuation Ratios | |
| Price Earnings | 21.50 |
| Price/Sales | 2.90 |
| Price/Book | 2.64 |
| Price/Cash Flow | 20.70 |
| Per Share Data | |
| Earnings | 1.72 |
| Sales | 12.74 |
| Book Value | 14.01 |
| Cash Flow | 1.78 |
| Business Summary | |
|---|---|
| Medicis Pharmaceutical Corporation focuses on helping patients attain a healthy and youthful appearance and self-image through the development and marketing in the U.S. of products for the treatment of dermatological and aesthetic conditions. | |
| General Information | |
| 7720 North Dobson Road
Scottsdale, AZ 85256 |
|
| www.medicis.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 646 | |
| CEO: Mr. Jonah Shacknai | |
| Short Interest | |
| Current Month (Mil) | 3.86 |
| Previous Month (Mil) | 3.60 |
| Short Interest Ratio (Days) | 2.70 |
| Management Effectiveness | |
| Return on Equity | 7.00 |
| Return on Assets | 3.90 |
| Return on Investments | 7.00 |
| Profitability | |
| Gross Margin | 90.80 |
| EBIT Margin | 27.30 |
| Profit Margin | 7.70 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,454.83 | 1,317.82 | 2,837.53 | 17.45 |
Oil *
106.76
|
|
DOWN
74.92 |
DOWN
2.86 |
DOWN
1.85 |
DOWN
0.14 |
10 Yr
1.74%
SPDR Gold
152.68
|
|
-0.60%
|
-0.22%
|
-0.07%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet